12:00 AM
 | 
Oct 07, 2013
 |  BC Week In Review  |  Company News  |  Deals

Gliknik, Pfizer deal

Pfizer received exclusive, worldwide rights to Gliknik's GL-2045, a recombinant stradomer designed to mimic IV Ig (...

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >